Mihai Miron, Ropharma: Pharmaceutical Market To Double In Ten Years

05.09.2018 By Mirabela Tiron

Romania has a lot to catch up on in terms of pharmaceutical consumption, the potential for growth is there, hence the interest of foreign investors, says entrepreneur Mihai Miron, who owns the Ropharma group, one of the largest in the country, as well as the Sf. Constantin Hospital in Brasov.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 25 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
pharmaceutical
, ropharma
, growth
, mihai miron

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.